Philip Morris’s Zyn nicotine pouch isn’t safe, but FDA gives OK to marketing it
Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...
Philip Morris International Inc. stock outperforms competitors on strong trading day
Philip Morris International Inc. closed $16.60 below its 52-week high ($134.15), which the company reached on October 31st.
Philip Morris International Inc. stock underperforms Tuesday when compared to competitors despite daily gains
This was the stock's second consecutive day of gains.
Philip Morris International Inc. (PM): A Bull Case Theory
We came across a bullish thesis on Philip Morris International Inc. (PM) on Substack by Chit Chat Stocks. In this article, we ...
Philip Morris International Inc. (NYSE:PM) Stock Position Boosted by Moody National Bank Trust Division
Moody National Bank Trust Division grew its stake in shares of Philip Morris International Inc. (NYSE:PM – Free Report) by ...
bovnews1d
Why Is Philip Morris International Inc. (PM) Stock Lagging Behind -4.83% from Its 50-Day SMA?
Philip Morris International Inc. (PM) stock saw a modest uptick, ending the day at $119.8 which represents a slight increase of $1.29 or 1.09% from the prior close of $118.51. The stock opened at $118 ...
Philip Morris stock rises on FDA's first nicotine pouch approval
Matthew Farrelly, Ph.D., director of the Office of Science in the FDA’s Center for Tobacco Products, stated, “In this case, ...
Czech National Bank Boosts Stock Position in Philip Morris International Inc. (NYSE:PM)
Czech National Bank increased its stake in shares of Philip Morris International Inc. (NYSE:PM – Free Report) by 6.4% during ...
bovnews5d
Why Philip Morris International Inc. (PM) Stock is Currently -4.68% Off from Its 20-Day SMA?
Philip Morris International Inc. (PM) stock saw a decline, ending the day at $117.15 which represents a decrease of $-4.71 or -3.87% from the prior close of $121.86. The stock opened at $119.96 and ...
Philip Morris Gains Competitive Edge with FDA Authorization of ZYN Nicotine Pouches
Analyst Matthew Smith of Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report), with a price target of ...
Buy Rating for Philip Morris: Strategic Positioning and FDA Approval of ZYN Pouches
Analyst Lisa Lewandowski from Bank of America Securities maintained a Buy rating on Philip Morris (PM – Research Report) and keeping the price ...
Yahoo Finance3d
Philip Morris Resilient on Smoke-Free Transition Efforts and Pricing
Philip Morris International Inc. PM has been making significant strides toward a smoke-free future. With a strong pricing strategy, innovative smoke-free products and disciplined cost-saving ...